meta_pixel
Tapesearch Logo
Log in
The World in Brief from The Economist

Ukraine’s hard choice; Trump meets Mamdani, and more

The World in Brief from The Economist

The Economist

Daily News, Global News, News, News & Politics

4.11.2K Ratings

🗓️ 22 November 2025

⏱️ 5 minutes

🧾️ Download transcript

Summary

Eli Lilly became the first drugmaker to reach a $1trn valuation

Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

The Economist

0:04.2

Hello, you're listening to the free edition of the world in brief from The Economist.

0:11.2

As a reminder, if you subscribe to The Economist, you'll get access to a deeper look at the day ahead, updated three times a day.

0:20.0

If you're already an economist subscriber, visit

0:22.9

economist.com slash espresso or visit our espresso app to start listening. Here's today's

0:29.4

free edition.

0:34.7

This is the world in brief from The Economist.

0:42.7

Our top stories.

0:45.7

Volodymy Zelensky, Ukraine's president, said America's proposed peace plan presented Ukraine with a choice between, quote, losing dignity or forfeiting American

0:57.7

support. The Trump administration has reportedly threatened to withhold weapons and suspend

1:04.1

intelligence sharing if Mr Zelensky does not agree to the deal.

1:09.4

European leaders have criticised their proposal, which appears to demand big concessions

1:14.6

from Ukraine, including ceding territory, to Russia.

1:20.4

Donald Trump said he had a, quote, great meeting in Washington with Zeran Mamdani,

1:25.8

adding that he believed New York City's mayor-elect would, quote,

1:30.0

surprise some conservative people. Speaking cordially from the Oval Office, after months of

1:36.4

bickering from afar, the pair said they discussed affordability in New York. America's president

1:43.2

suggested he would help the city, seemingly retreating on earlier threats

1:47.9

to withhold crucial federal funds.

1:52.3

Eli Lilly became the first drug maker to reach a $1 trillion valuation.

1:58.3

The American firm's stock has risen by more than 35% this year on the success of

2:03.9

its weight loss drugs. Its products made up nearly 60% of prescriptions for such drugs in America.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Economist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Economist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.